Corporate Board Profile
Tech Score: 57/100
4 mention(s) identify GARY R. MAHARAJ as having software/technology expertise.
Company | Filing Date | Evidence | Reason |
---|---|---|---|
NVE CORP /NEW/ | 2016-06-20 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics from the University of the West Indies. Mr. Maharaj’s over 25 years experience in the medical technology industry, his experience as an executive officer and director of a publicly traded company, and his scientific and engineering education qualify him to serve as a director. | Mr. Maharaj holds an M.S. in biomedical engineering and a B.Sc. in Physics, with over 25 years of experience in medical technology and engineering roles, indicating technical and programming capabilities. |
NVE CORP /NEW/ | 2018-06-18 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics. | Holds an M.S. in biomedical engineering and has over 30 years of experience in medical technology, including research and development roles indicating technical and programming skills. |
NVE CORP /NEW/ | 2019-06-17 | Mr. Maharaj holds an MBA, an M.S. in biomedical engineering, and a B.Sc. in Physics. He served as Vice President of Research and Development at Augustine Medical, Inc. | Holds an M.S. in biomedical engineering and has experience as Vice President of Research and Development, indicating technical and programming skills. |
NVE CORP /NEW/ | 2020-06-22 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics. | Holds an M.S. in biomedical engineering and has experience as Vice President of Research and Development, indicating technical and engineering expertise. |
Filing Date | Source Excerpt |
---|---|
2014-06-23 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics from the University of the West Indies. |
2015-06-22 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics from the University of the West Indies. |
2016-06-20 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics from the University of the West Indies. Mr. Maharaj’s over 25 years experience in the medical technology industry, his experience as an executive officer and director of a publicly traded company, and his scientific and engineering education qualify him to serve as a director. |
2017-06-19 | Mr. Maharaj holds an MBA, an M.S. in biomedical engineering, and a B.Sc. in Physics. He has over 29 years experience in the medical technology industry. |
2018-06-18 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics. |
2019-06-17 | Mr. Maharaj holds an MBA, an M.S. in biomedical engineering, and a B.Sc. in Physics. He served as Vice President of Research and Development at Augustine Medical, Inc. |
2020-06-22 | Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics. |
Data sourced from SEC filings. Last updated: 2025-07-01